In this study, significantly higher levels of plasma anti-TIF1-γ antibodies were observed among the Cancer TIF1-γ-DM patients than the Non-cancer TIF1-γ-DM patients (Figure 1A). The gene discussed is TRIM33; the disease is cancer.